Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “calcium”

95 pharma patents match "calcium" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 95
Index total 30,257
Page 1 / 4

Quick answer

This filtered view shows 95 pharmaceutical patents matching "calcium" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

95 results for “calcium” · 30,257 patents in full index Clear search

  1. US 12351609

    Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

    The Board of Regents of the University of Texas System · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted

  2. US 12257224

    Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker

    Milestone Pharmaceuticals Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted

  3. US 12202832

    Heterocyclic compounds having a calcium-sensing receptor antagonistic activity

    Takeda Pharmaceutical Company Limited · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted

  4. US 12077502

    Formulations of T-type calcium channel modulators and methods of use thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted

  5. US 11773138

    Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

    Theradaptive, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  6. US 11649207

    Formulations of T-type calcium channel modulators and methods of use thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  7. US 11427540

    Formulations of T-type calcium channel modulators and methods of use thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  8. US 11358947

    Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  9. US 11192923

    Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

    Theradaptive, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  10. US 11111278

    Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

    The Board of Regents of the University of Texas System · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  11. US 11103528

    Slow release calcium composition

    United States of America as represented by the Secretary of the Air Force · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

  12. US 10766908

    Calcium L-lactate frameworks as naturally degradable carriers

    The Regents of the University of California · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

  13. US 10675246

    Orally administrable compositions comprising calcium

    CEROLIFE LLC · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  14. US 10617136

    Calcium oxide compound with high purity

    ARKIM KIMYEVI MADDELER SANAYI VE TICARET ANONIM SIRKETI · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted

  15. US 10570183

    Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

    The Board of Regents of the University of Texas System · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  16. US 10357460

    Particulate comprising a calcium-containing compound and a sugar alcohol

    TAKEDA AS · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  17. US 10258576

    Particulate comprising a calcium-containing compound and a sugar alcohol

    TAKEDA AS · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  18. US 10117848

    Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  19. US 10105366

    Selective calcium channel antagonists

    Northwestern University · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  20. US 10092593

    Citrate-rich calcium-magnesium supplement and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  21. US 10058587

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  22. US 10010523

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  23. US 10010522

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  24. US 10010524

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.